학술논문

Long-term Efficacy of Ozanimod by Age Category in Patients With Relapsing Multiple Sclerosis in Two Phase 3 Trials and an Open-label Extension Trial
Document Type
Journal
Source
MULTIPLE SCLEROSIS JOURNAL; MAY 2023, 29 p55-p56, 2p. Supplement: 2
Subject
Language
English
ISSN
14770970